Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03485040 · ClinicalTrials.gov registry record
Stroke Motor Rehabilitation and Recovery Study
A clinical trial of Stroke, Ischemic, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT03485040: Recruiting study of Stroke, Ischemic, sponsored by Massachusetts General Hospital.
NCT03485040 is a study of Stroke, Ischemic that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 300 participants, roughly in line with the 281-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03485040, a study of Stroke, Ischemic, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
SMaHRT (Stroke Motor reHabiliation and Recovery sTudy) is a longitudinal study aimed at understanding the natural history of upper extremity motor recovery after ischemic and hemorrhagic stroke.
Primary Outcome
This test provides information about level of upper extremity motor impairment after stroke. The test includes a series of different movements that allow for the assessment of functional movement capacity and quality. The scale is used to track change in upper extremity motor impairment over the course of one year post stroke.
Conditions Studied
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2017-06-09 |
| Est. Completion | 2027-06-30 |
What NCT03485040 shows while recruiting
NCT03485040 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 281-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target.
The record links to 1 condition, with Stroke, Ischemic appearing as the primary indexed condition, and to 0 interventions.
NCT03485040 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03485040 about?
NCT03485040 is a clinical study titled "Stroke Motor Rehabilitation and Recovery Study". SMaHRT (Stroke Motor reHabiliation and Recovery sTudy) is a longitudinal study aimed at understanding the natural history of upper extremity motor recovery after ischemic and hemorrhagic stroke.
What is the current status of trial NCT03485040?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2017-06-09. Estimated completion is 2027-06-30.
What conditions does trial NCT03485040 study?
This clinical trial studies the following conditions: Stroke, Ischemic.
Who is sponsoring clinical trial NCT03485040?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03485040 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Ischemic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03485040's enrollment target sits among peer trials
300 7th of 33 higher than 26 of 33 other Stroke, Ischemic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke, Ischemic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
RECRUITING · NA
-
DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients)
RECRUITING
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
-
Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
RECRUITING
-
Intra-Arterial Neuroprotective Agents and Cold Saline in Ischemic Stroke Intervention
RECRUITING · Phase 1
-
Promoting Recovery After STroke With Amantadine
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI